TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
MedPharm Consult AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
722
|
148
|
453 |
Financial expenses |
1
|
2
|
0 |
Earnings before taxes |
339
|
77
|
222 |
EBITDA |
341
|
79
|
222 |
Total assets |
700
|
237
|
471 |
Current assets |
692
|
228
|
466 |
Current liabilities |
268
|
74
|
168 |
Equity capital |
419
|
150
|
290 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
2
|
0
|
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
59.9%
|
63.3%
|
61.6% |
Turnover per employee | 361 | 453 | |
Profit as a percentage of turnover |
47.0%
|
52.0%
|
49.0% |
Return on assets (ROA) |
48.6%
|
33.3%
|
47.1% |
Current ratio |
258.2%
|
308.1%
|
277.4% |
Return on equity (ROE) |
80.9%
|
51.3%
|
76.6% |
Change turnover |
574
|
-305
|
453 |
Change turnover % |
388%
|
-67% | |
Chg. No. of employees |
2
|
-1
|
1 |
Chg. No. of employees % | -100% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.